INVO Fertility (IVF) Gains from Investment Securities (2020 - 2024)
INVO Fertility (IVF) reported Gains from Investment Securities of $507129.0 for Q4 2024, up 914.26% sequentially from $50000.0 in Q2 2024.
INVO Fertility (IVF) Gains from Investment Securities (2020 - 2024) Analysis & Trends
INVO Fertility has disclosed Gains from Investment Securities across 5 years of filings, most recently posting $507129.0 for Q4 2024.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $507129.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$4534.0 (changed N/A YoY) and the FY2024 annual result came in at -$4534.0, changed N/A from the prior year.
- Gains from Investment Securities grew to $507129.0 in Q4 2024, from $50000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.5 million in Q3 2022 and bottomed at -$561663.0 in Q1 2024.
- The 5-year median for Gains from Investment Securities is $99595.5 (2021), against an average of $328923.4.
- The widest YoY moves for Gains from Investment Securities: up 2031.29% in 2024, down 488.41% in 2024.
- INVO Fertility's Gains from Investment Securities stood at $56509.0 in 2020, then tumbled by 95.76% to $2395.0 in 2021, then surged by 61678.91% to $1.5 million in 2022, then slumped by 92.39% to $112628.0 in 2023, then surged by 350.27% to $507129.0 in 2024.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $507129.0, $50000.0, and -$561663.0 for Q4 2024, Q2 2024, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.31 Mn | 4.91 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 507,129.00 |
| Dec 31, 2024 | 507,129.00 |
| Jun 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | -561,663.00 |
| Mar 31, 2024 | -561,663.00 |
| Sep 30, 2023 | 112,628.00 |
| Sep 30, 2023 | 112,628.00 |
| Jun 30, 2023 | 2,346.00 |
| Jun 30, 2023 | 2,346.00 |
| Mar 31, 2023 | 144,606.00 |
| Mar 31, 2023 | 144,606.00 |
| Sep 30, 2022 | 1.48 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 187,861.00 |
| Jun 30, 2022 | 187,861.00 |
| Mar 31, 2022 | 1.47 Mn |
| Mar 31, 2022 | 1.47 Mn |
| Dec 31, 2021 | 2,395.00 |
| Dec 31, 2021 | 2,395.00 |